Menu Back toArtificial-Intelligence-A-Disruptive-Journey-for-Pharmacovigilance

DIA 2018 Global Annual Meeting


Artificial Intelligence: A Disruptive Journey for Pharmacovigilance

    Session Chair(s)
      Annette S. Williams, MBA, RPh

      Annette S. Williams, MBA, RPh

      • Vice President, Lifecycle Safety
      • IQVIA, United States
    to be determined
    Learning Objective : Understand the in depth process for training cognitive systems through a practical example like MedDRA coding, including data type, volume and quality and challenges to prepare for Outline Subject Matter Expertise requirements needed to train a cognitive system along with the iterative training process Relay the ongoing training that may be required, expected results, reasons, and process
    Speaker(s)
      Elenee  Argentinis, JD

      Training Artificial Intelligent System for Pharmacovigilance: Practical Considerations and Guidance

      Elenee Argentinis, JD

      • Offering Management Leader
      • IBM Watson Health, United States
      Glenn  Carroll, MBA

      The Future of Pharmacovigilance After Full Industry Disruption from Cognitive Automation

      Glenn Carroll, MBA

      • Principal, Strategy and Operations, Life Sciences
      • Deloitte Consulting, United States
      Caroline  Rosewell, MBA

      Our Journey Toward Touchless Case Management

      Caroline Rosewell, MBA

      • Senior Director, Global Patient Safety, Clinical Case Management
      • Eli Lilly and Company, United States